Vimta Labs Merger & Restructuring Worth ₹0.08 Cr

Vimta Labs Earnings Call Transcript: Key Takeaways

Stable Q2 performance masked by R&D lulls and logistics headwinds.

Call

Guides 25% growth

Vimta Labs Results Update

Vimta Labs reported Q2 FY27 income of ₹1,149 Mn, up 9.9% YoY, and PAT of ₹206 Mn at 17.9% margin. EBITDA margins held steady at 35.5%.

Vimta Labs Investor Presentation: Key Takeaways

Q2 FY27: total income Rs1,149Mn (+9.9% YoY), EBITDA Rs408Mn (35.5% margin), PAT Rs206Mn (17.9% margin, +3.5% YoY). H1 FY27 PAT Rs417Mn (+7.3%).

Vimta Labs Q2 FY27 Results: Net Profit ₹20.6 Cr, Up 3.5% YoY

Vimta Labs Ltd reported revenue from operations of ₹112 Cr (+10.0% YoY) and net profit of ₹20.6 Cr (+3.5% YoY) for Q2 FY27.

Key figure

Net profit ₹20.6 Cr · +3.5% YoY

Vimta Labs Board Meeting Date

Vimta Labs will hold a board meeting on 30 October 2026 to consider half-year results. Trading window stays closed from 01 October.

Vimta Labs Other Announcement

Vimta Labs Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.

Oricon Enterprises Merger & Restructuring Worth ₹145 Cr

Oricon Enterprises sold its leasehold land and building to Anand Rathi Towers for Rs.145 Crore. The sale is completed and the buyer is unrelated to promoters.

Value

₹145.0 Cr

Clean Max Enviro Energy Solutions Merger & Restructuring Worth ₹0 Cr

Sale of 26% stake in subsidiary Clean Max Alps to Bayer Vapi for ₹0.0026 Crore. The subsidiary contributed no revenue or net worth last financial year.

Value

₹0.00 Cr

Weagro Merger & Restructuring Worth ₹0.01 Cr

Weagro will incorporate a wholly-owned Singapore subsidiary, Weagro Pte Ltd, with initial investment up to SGD 100,000. The move expands its agro business into Singapore.

Value

₹0.01 Cr

Execution

Within two months from the date of the Board decision, subject to statutory approvals.

Tejassvi Aaharam Merger & Restructuring

Tejassvi Aaharam (now WEAGRO) approved a wholly-owned subsidiary in Singapore and a Dubai branch office. The initial investment is up to SGD 100,000.

Execution

Within two months from the board decision, subject to statutory approvals

Ginni Filaments Merger & Restructuring

Ginni Filaments incorporated a wholly owned subsidiary, Ginni RSA (Pty) Ltd, in South Africa. The subsidiary will trade and distribute wet wipes internationally.

Thyrocare Technologies Merger & Restructuring Worth ₹141.4 Cr

Thyrocare agreed to sell its entire stake in subsidiary Nueclear Healthcare to Trovera. The consideration is about Rs 141.40 Crore, including preference shares and cash.

Value

₹141.4 Cr